The board of directors of medical technology company CONMED Corporation (NASDAQ:CNMD) authorised a quarterly dividend of USD0.20 per share of the company's stock, it declared on Friday.
Shareholders of record as of 13 September 2019 will receive the cash dividend on 7 October 2019.
CONMED provides surgical devices and equipment for minimally invasive procedures.
According to CONMED, its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government